Clinical Trials · NCT02805790
Safety, Tolerability, Efficacy of MTP-131 for Treatment of Mitochondrial Disease in Subjects From the MMPOWER Study
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Stealth BioTherapeutics Inc.
- Enrollment
- 30
- Start date
- Aug 2016
- Locations
- 4 sites, United States
- Primary endpoint
- Distance Walked on the 6-minute Walk Test (6MWT) by Visit